ArticleJournal of Cancer2021

Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.